THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 1,370,250 Value ($000) $12,414 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 3,254,713 Value ($000) $31,115 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 5,974,535 Value ($000) $66,019 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 5,895,159 Value ($000) $43,624 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 4,564,045 Value ($000) $66,270 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 6,219,110 Value ($000) $126,932 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 6,219,110 Value ($000) $110,514 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 6,219,110 Value ($000) $91,950 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 2,554,470 Value ($000) $53,618 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 211,545 Value ($000) $4,889 Avg Close $25.03 Range $16.86 - $31.54